Most Recent

image: Opinion: After We March

Opinion: After We March

By | March 16, 2017

How to become—and stay—involved in science policy 

4 Comments

image: Opinion: Sometimes, Scientists Must March

Opinion: Sometimes, Scientists Must March

By , , and | February 13, 2017

Lessons learned from the “Death of Evidence” demonstration in Canada

9 Comments

Mentoring is critical for students just beginning to learn the ropes of biomedical research.

5 Comments

image: Opinion: Toot Your Horn

Opinion: Toot Your Horn

By | October 6, 2016

Why (and how) scientists should advocate for their research with journalists and policymakers

3 Comments

image: Opinion: Experiences of an Itinerant Scientist

Opinion: Experiences of an Itinerant Scientist

By | July 14, 2015

What I’ve learned doing science in three different countries 

1 Comment

image: Opinion: How Postdocs Can Participate

Opinion: How Postdocs Can Participate

By | September 18, 2014

Graduate students and postdoctoral researchers should be taking part in discussions on the future of biomedical research.

6 Comments

image: Opinion: A Role for Community Science Clubs

Opinion: A Role for Community Science Clubs

By , , and | July 29, 2014

How retired scientists can enhance science education where they reside

2 Comments

image: Opinion: The Pitfalls of Uncertainty

Opinion: The Pitfalls of Uncertainty

By | April 14, 2014

How to successfully inform policy when scientific evidence is not plainly evident.

2 Comments

image: Opinion: Researching the Researchers

Opinion: Researching the Researchers

By | November 25, 2013

The biomedical research community is due for some self-reflection.

9 Comments

image: Opinion: Who We Work For

Opinion: Who We Work For

By | November 5, 2013

On winning hearts, minds, and votes for science

1 Comment

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham